Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer

Sheryl R. Krig, Seth Frietze, Catalina Simion, Jamie K. Miller, Will H.D. Fry, Hanine Rafidi, Lakmal Kotelawala, Lihong Qi, Obi L. Griffith, Joe W. Gray, Kermit L. Carraway, Colleen Sweeney

Research output: Contribution to journalArticle

44 Scopus citations

Fingerprint Dive into the research topics of 'Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences